Table 1.
Guideline | Pre-pasteurization: Total confluent bacterial growth | Pre-pasteurization: Additional criteria | Post-pasteurization |
---|---|---|---|
France: Bonnes pratiques des lactariums2 | Total (aerobic) flora ≤ 106 CFU/mL | Staphylococcus aureus ≤ 104 CFU/mL | Any microbial growth |
Italy: Guidelines for the establishment and operation of a donor human milk bank (13) | ≤ 105 CFU/mL | Enterobacteriaceae or Staphylococcus aureus ≤ 104 CFU/mL | ≤ 10 CFU any organism |
Sweden: Guidelines for the use of human milk and milk handling in Sweden 1 | Total aerobic bacteria: No upper limit | • Any pathogenic bacteria from the following‘: • Betahemolytic Streptococci group A, C, or G, Streptococci group B, Listeria, or Salmonella <104 CFU/ml • Enterobacteriaceae • Staphylococcus aureus • Pseudomonas aeruginosa or other Pseudomonas species • Stenotrophomonas maltophilia • Acinetobacter species |
Total aerobic count ≤ 10 CFU/ml. No pathogenic bacteria are accepted |
United Kingdom: NICE Clinical Guideline 93. Donor milk banks; service operation (14) | ≤ 105 CFU/mL | Enterobacteriaceae or Staphylococcus aureus ≤ 104 CFU/mL | ≤ 10 CFU any organism |
Australia: Best practice guidelines for the operation of a donor human milk bank in an Australian NICU (20) | ≤ 105 CFU/mL | Any Enterobacteriaceae, Enterococci or potential pathogens capable of producing heat-stable enterotoxins | Any microbial growth |
United States of America (HMBANA): Guidelines for the Establishment and Operation of a Donor Human Milk Bank 2018a | Pre-pasteurization testing not included in the recommendations | Pre-pasteurization testing not included in the recommendations | “Any bacteriological growth is unacceptable for heat-processed milk” |
Human Milk Bank Association of North America. http://hmbana.org.